US Medical Affairs - GI Oncology Summer Intern (Doctoral) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 1 week ago

US Medical Affairs - GI Oncology Summer Intern (Doctoral)

positionGaithersburg, Maryland, United States of America
timeInternship
remoteOnsite
seniorityIntern
money$40/hr - $48/hr
workcardStart in 2026 Spring

Alexion Pharmaceuticals, Inc. is seeking PhD and PharmD students for a 12-week internship role in their US Medical Affairs - GI Oncology team. The intern will analyze medical insights, develop scientific materials for education, and explore technologies to enhance efficiency in medical affairs.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & BenefitsbadNo H1Bnote

Responsibilities

Analyze and synthesize medical insights from multiple sources to inform medical strategy and tactics
Develop external-facing scientific materials to support ongoing medical education efforts
Explore internal technologies to enhance medical affairs efficiency and impact within the USMA- Oncology GI team

Qualification

PhD in life sciencesPharmD in pharmaceuticalsOncology research experienceAnalytical skillsPublic speakingPresentation designPresentation skillsCollaboration

Required

PhD and PharmD students studying life sciences and/or pharmaceuticals
Strong scientific background is required
Candidates must have an expected graduation date after August 2026
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week

Preferred

Analytical and presentation skills are preferred
Prior oncology research experience is a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Alexion Pharmaceuticals, Inc.

twittertwittertwitter
Glassdoor3.9
company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
dateFounded in 1992
location
Boston, Massachusetts, USA
people-size1001-5000 employees
web-link
https://alexion.com

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin

Recent News

bloomberglaw.com
AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case
2025-12-20
Business Wire
Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com
2025-12-01
EuropaWire
AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results
2025-11-20
Company data provided by crunchbase